Galectin Therapeutics

+$0.13 (+4.96%) Today
+$0.09 (+3.27%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GALT and other ETFs, options, and stocks.

About GALT

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments.

CEO
Joel Lewis
Employees
6
Headquarters
Norcross, Georgia
Founded
2000

GALT Key Statistics

Market Cap
245.13M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
306.62K
High Today
$2.76
Low Today
$2.60
Open Price
$2.64
Volume
234.10K
52 Week High
$5.70
52 Week Low
$1.82

GALT News

Simply Wall StJul 30

Here's What Galectin Therapeutics Inc.'s Shareholder Ownership Structure Looks Like

Every investor in Galectin Therapeutics Inc. (NASDAQ:GALT) should be aware of the most powerful shareholder groups. Insiders often own a large chunk of younger,

GALT Earnings

-$0.17
-$0.11
-$0.06
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 12, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure